A favorable appeals court ruling repositioned a coalition of universities and Nobel laureates to win credit for inventing a ...

The CRISPR-Cas9 patent landscape remains complex and unsettled. The Federal Circuit’s latest decision in University of California v.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The 20 men and 10 women of the latest cycle represent various cultural backgrounds, including individuals of Korean, Taiwanese, and Samoan heritage. With them comes foreign language proficiencies ...

The tool, which relies on generative artificial intelligence, is designed to enhance chat personalisation by creating unique backgrounds based on user input. According to a report by WABetaInfo ...

It allows the evaluation of the quality of gene editing experiments using targeted next generation sequencing (NGS) data (`targeted`) as well as the discovery of important genes from knock-out or ...

The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs ...

(CNN) — When President Donald Trump welcomes his new Canadian counterpart to the White House on Tuesday, among the questions looming over their Oval Office encounter will be whether Trump will ...

(CNN) — Laura Loomer can get President Donald Trump on the phone, but she can’t get a seat in his briefing room. As the White House opens its doors to a new class of media personalities ...

The White House is unveiling President Donald Trump’s budget, a sweeping framework proposing steep reductions in non-defense domestic spending while increasing expenditures on national security.

A productive cough can bring up mucus from the lungs. Mucus can be several different colors, such as white, green, and yellow, which can all indicate different issues, such as an infection or ...

This was good enough for making GMO corn but not enough for human medicine. So when, in 2012, Jennifer Doudna and Emmanuelle Charpentier discovered CRISPR-Cas9, a lot of hopes grew. This is because ...